Hypotension resistant to therapy with α receptor agonists complicating cardiopulmonary bypass: Lithium as a potential cause

Anesthesia and Analgesia

Volumn 82, Issue 5, 1996, Pages 1082-1085

  Berkowitz, Dan E ^a   Richardson, Charlene ^a   Elliott, Denise A ^a   Leslie, John B ^a   Schwinn, Debra A ^a,b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CEPHALOSPORIN DERIVATIVE; DIAZEPAM; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENTANYL; LISINOPRIL; LITHIUM CARBONATE; METHADONE; MIDAZOLAM; NORADRENALIN; PHENYLEPHRINE; VECURONIUM;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; CORONARY ARTERY DISEASE; DIABETIC NEUROPATHY; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY;

EID: 0029935709     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199605000-00038     Document Type: Article

References (23)

1. Rosenthal NE, Goodwin EK. The role of the lithium ion in medicine. Annu Rev Med 1982;33:555-68.
2. Wickham EA, Reed JV. Lithium in the control of aggressive and self mutilating behavior. Int Clin Psychopharmacol 1987;2:181-90.
3. Ekbom K. Lithium for cluster headache. Headache 1982;21:132-9.
4. Jephcott GR, Kerry RJ. Lithium: an anesthetic risk. Br J Anaesth 1974;46.
5. Mannisto FT, Saarnivarru L. Effects of lithium and rubidium on the sleeping time caused by various intravenous anesthetics in the mouse. Br J Anaesth 1976;48:185-90.
6. Hill GE, Wong KC. Lithium carbonate and neuromuscular blocking agents. Anesthesiology 1977;46:122-6.
7. Hill GE, Wong KC, Hodges MR. Potentiation of succinylcholine neuromuscular blockade by lithium carbonate. Anesthesiology 1976;44:439-42.
8. Allison JH, Stewart MA. Reduced brain inositol in lithium treated rats. Nature 1971;233:267-8.
9. Allison JH, Stewart MA. Inhibition of the effect of lithium on brain inositol by atropine and scopolamine. Biochem Biophys Res Commun 1976;68:1332-8.
10. Berridge MJ, Downes CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982;206:587-95.
11. Sherman WR, Leavitt AL, Honchar MP, et al. Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat. J Neurochem 1981;36:1947-51.
12. Beridge MR, Dowries CP, Hanley MR. Neural and developmental action of lithium: a unifying hypothesis. Cell 1989;59:411-9.
13. Nahorski SR, Ragan CI, Challiss RAJ. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol Sci 1991;12:297-303.
14. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989;341:197-205.
15. Massagee JT, McIntyre RW, Kates RA, et al. Effects of preoperative calcium entry blocker therapy in patients undergoing coronary revascularization. Anesthesiology 1987;67:485-91.
16. Kellow NH. The renin-angiotensin system and angiotensin converting enzyme (ACE) inhibitors. Anaesthesia 1994;49:613-22.
17. Myles PS, Olenikov I, Bujor MA, et al. ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study. Med J Aust 1993;158:675-7.
18. Tuman KJ, McCarthy RJ, O'Connor CJ, et al. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anes Analg 1995;80:473-9.
19. Balla T, Enyedi P, Hunyady L, et al. Effects of lithium on angiotensin-stimulated phosphatidylinositol turnover and aldosterone production in adrenal flomerulosa cells: a possible causal relationship. FEBS Lett 1984;171:179-82.
20. Lomasney JW, Cotecchia S, Lefkowitz RJ, et al. Molecular biology of alpha adrenergic receptors: implications for receptor classification and for structure-function relationships. Biochim Biophys Acta 1991;1095:127-39.
21. 2+. Pharmacol Rev 1988;40:87-119.
22. Smrcka AV, Helper JR, Brown KO, et al. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science 1991;251:804-7.
23. Mignat C, Unger T. ACE inhibitors: drug interactions of clinical significance. Drug Saf 1995;12:334-47.